Leerink Partners Has Lowered Expectations for CVS Health (NYSE:CVS) Stock Price

Key Points

• Leerink Partners lowered its CVS Health price target from $119 to $112 while maintaining an “outperform” rating, implying approximately 30% upside from the stock’s $86.15 price.
• Analyst sentiment remains broadly positive, with 20 Buy ratings and three Holds; MarketBeat reports a “Moderate Buy” consensus and an average target price of $107.80.
• CVS exceeded quarterly expectations, reporting $2.58 in EPS versus the $1.87 consensus and $106.1 billion in revenue, up 7.3% year over year. The company guided to fiscal 2026 EPS of $7.90–$8.10.

CVS Health (NYSE:CVS - Get Free Report) had its price objective cut by investment analysts at Leerink Partners from $119.00 to $112.00 in a note issued to investors on Monday, Benzinga reports. The firm currently has an "outperform" rating on the pharmacy operator's stock. Leerink Partners' price objective would indicate a potential upside of 30.01% from the company's current price.

Other equities analysts also recently issued research reports about the stock. HSBC reissued a "hold" rating and set a $103.00 price target on shares of CVS Health in a report on Monday, July 6th. UBS Group reaffirmed a "buy" rating on shares of CVS Health in a report on Tuesday, September 22nd. Piper Sandler set a $112.00 price objective on shares of CVS Health in a report on Wednesday, September 9th. Cantor Fitzgerald reiterated a "neutral" rating on shares of CVS Health in a research report on Friday. Finally, BMO Capital Markets set a $112.00 target price on shares of CVS Health in a research note on Wednesday, September 9th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $107.80.

CVS Health Stock Down 0.0%

Shares of CVS Health stock opened at $86.15 on Monday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The business's 50 day simple moving average is $92.73 and its 200-day simple moving average is $92.52. The stock has a market capitalization of $110.18 billion, a price-to-earnings ratio of 22.79, a PEG ratio of 0.80 and a beta of 0.60. CVS Health has a twelve month low of $69.51 and a twelve month high of $110.68.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same quarter last year, the business posted $1.81 EPS. The business's revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts forecast that CVS Health will post 8.02 earnings per share for the current year.

Institutional Investors Weigh In On CVS Health

Several institutional investors have recently bought and sold shares of CVS. Kilter Group LLC acquired a new stake in CVS Health in the 2nd quarter valued at approximately $27,000. Beaird Harris Wealth Management LLC lifted its holdings in shares of CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock worth $30,000 after buying an additional 195 shares during the last quarter. J.Safra Asset Management Corp acquired a new position in shares of CVS Health during the second quarter worth approximately $30,000. Timbuktu Capital Management LLC acquired a new position in shares of CVS Health during the second quarter worth approximately $31,000. Finally, Dunhill Financial LLC bought a new stake in shares of CVS Health in the second quarter valued at approximately $32,000. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Company Profile

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company's major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.